Company / Gross Margin
Amgen Gross Margin History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
18.5%
FY2019
5-year range
-
FY2016-FY2019
Trend
-3.2%
vs FY2018
Sector context
#28 of 28
Health Care
What the data says
Among 28 Health Care companies, Amgen is in the bottom 0% for gross margin. Gross Margin has declined for 3 consecutive years, from 21.0% in FY2016 to 18.5% in FY2019.
Based on SEC 10-K filings.
18.5% in FY2019 with a 3-year CAGR of -2.5%.
Declined from 19.4% to 18.5% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -2.5pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 28This company 18.5% Sector average 60.3%
▼
-69.3% below sector average
Key checks
Key Insights
- Amgen's gross margin has declined for 3 consecutive years.
- In FY2019, gross margin decreased 3.2% year-over-year.
- Currently 41.8pp below the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | 18.5% | -3.2% |
| FY2018 | 19.1% | -1.4% |
| FY2017 | 19.4% | -7.8% |
| FY2016 | 21.0% | +18.7% |
As of FY2019 · SEC 10-K · Updated Jun 30, 2026